Sponsored Links
| Biomoda Adds Clinical Site To Lung Cancer Study |
 |
 |
 |
| Medical News - Cancer Oncology | |||
|
Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) announced that Waterbury Pulmonary Associates Research has joined the pilot clinical study of Biomoda's CyPath® diagnostic assay. Waterbury Pulmonary Associates Research is enrolling participants for the positive control group, patients diagnosed with lung cancer who have not yet started treatment... Read more: Cancer / Oncology News From Medical News Today
|